Review Article
Nedaplatin: A Radiosensitizing Agent for Patients with Cervical Cancer
Table 3
Patient characteristics and treatment outcomes (High-risk patients).
| | | | RT-group | CCRT-group | -value |
| Patient characteristics | Number of patients | | 34 | 34 | | Age (mean) | | 51.3 | 50.1 | | Clinical stage | IA2 | 0 | 0 | | IB | 7 | 12 | | IIA | 9 | 2 | | IIB | 18 | 20 | | Histology | Squamous cell | 21 | 25 | | Adenocarcinoma | 13 | 8 | | Adenosquamous | 0 | 1 | | Others | 0 | 0 | |
| Treatment outcome | Duration of radiotherapy | Days | 38 | 38 | NS | Patients with recurrence (%) | | 16 (47.0) | 9 (26.5) | NS | PFS (months) | Mean | 22.6 | 29.5 | NS | OS (months) | Mean | 29.7 | 34.2 | .0364 |
|
|
PFS: progression-free survival, OS: overall survival, CCRT: concurrent chemoradiotherapy, RT: radiotherapy.
|